Trademarkia Logo

Canada

C$
Trademark Search in Canada
DIVERGIMAB

View On IC.GC.CA

DIVERGIMAB
ADVERTISED

on 13 Nov 2024

Last Applicant/ Owned by

AbX Biologics, Inc.

480 Neponset Street, Suite 10BCanton MA 02021

US

Serial Number

2199076 filed on 12th Jan 2022

Correspondent Address

SMART & BIGGAR LP

SUITE 1000, 55 METCALFE STREETP.O. BOX 2999, STATION DOTTAWA

ONTARIO

CA

K1P5Y6

DIVERGIMAB

Trademark usage description

genetic research services for others, namely, scientific research for others in the field of genetics; platform antibody-based therapeutics and reagen Read More

Classification Information

Class [042]
Genetic research services for others, namely, scientific research for others in the field of genetics; platform antibody-based therapeutics and reagent discovery for medical research purposes; the generation of therapeutic and reagent antibodies for medical research purposes; genetic engineering services, namely, the production of genetically-engineered mice and antibodies for others.

Classification kind code

11

Mark Details

Serial Number

2199076

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 10th Feb 2024		Agent Changed
Submitted for opposition 22
on 30th Oct 2023		Search Recorded
Submitted for opposition 20
on 30th Oct 2023		Examiner's First Report
Submitted for opposition 223
on 30th Oct 2023		Total Provisional Refusal
Submitted for opposition 256
on 22nd May 2023		Notification of Possible Opposition Sent
Submitted for opposition 257
on 21st Jul 2022		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 20th Jul 2022		Created
Submitted for opposition 31
on 20th Jul 2022		Formalized
Submitted for opposition 30
on 12th Jan 2022		Filed
Submitted for opposition 228
on 12th Jan 2022		International Registration